Blueprint, a developer of patient tracking and outcomes assessment tools for mental health clinicians, raised $9 million in Series A funds, CEO Danny Freed tells Axios exclusively.
Why it matters: While recent allegations of misconduct among telemental health startups have grabbed headlines, the traditional therapy industry lacks technology-based tools to assess the efficacy of its treatments.